These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 19705781)

  • 1. [Isolation and characterization of collagen-binding domains from human von Willebrand factor].
    Sharapova NE; Kotnova AP; Galushkina ZM; Poletaeva NN; Lavrova NV; Aksenova EI; Semikhin AS; Kariagina AS; Lunin VG
    Mol Gen Mikrobiol Virusol; 2009; (3):31-5. PubMed ID: 19705781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The secondary structure of the von Willebrand factor type A domain in factor B of human complement by Fourier transform infrared spectroscopy. Its occurrence in collagen types VI, VII, XII and XIV, the integrins and other proteins by averaged structure predictions.
    Perkins SJ; Smith KF; Williams SC; Haris PI; Chapman D; Sim RB
    J Mol Biol; 1994 Apr; 238(1):104-19. PubMed ID: 8145250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary binding domain of bovine von Willebrand factor fragment expressed in E. coli.
    Bakhshi MR; Sinha D; Vora RK; Budzynski AZ; Kirby EP
    Thromb Haemost; 1996 Jan; 75(1):196-202. PubMed ID: 8713801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation and characterization of a recombinant single chain Fv antibody to von Willebrand factor A1 domain from phage display library.
    Zhu H; Wang Y; Jiang M; Ji S; Bai X; Ruan C
    Thromb Res; 2005; 116(5):385-91. PubMed ID: 16122551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mapping von Willebrand factor A domain binding sites on a snake venom metalloproteinase cysteine-rich domain.
    Pinto AF; Terra RM; Guimaraes JA; Fox JW
    Arch Biochem Biophys; 2007 Jan; 457(1):41-6. PubMed ID: 17118332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Laboratory diagnosis of von Willebrand disease type 1/2E (2A subtype IIE), type 1 Vicenza and mild type 1 caused by mutations in the D3, D4, B1-B3 and C1-C2 domains of the von Willebrand factor gene. Role of von Willebrand factor multimers and the von Willebrand factor propeptide/antigen ratio.
    Gadisseur A; Berneman Z; Schroyens W; Michiels JJ
    Acta Haematol; 2009; 121(2-3):128-38. PubMed ID: 19506359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dominant von Willebrand disease type 2M and 2U are variable expressions of one distinct disease entity caused by loss-of-function mutations in the A1 domain of the von Willebrand factor gene.
    Gadisseur A; van der Planken M; Schroyens W; Berneman Z; Michiels JJ
    Acta Haematol; 2009; 121(2-3):145-53. PubMed ID: 19506361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of a novel mutation in the von Willebrand factor propeptide in a distinct subtype of recessive von Willebrand disease.
    Lanke E; Kristoffersson AC; Philips M; Holmberg L; Lethagen S
    Thromb Haemost; 2008 Aug; 100(2):211-6. PubMed ID: 18690339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascularization and cellularization of collagen scaffolds incorporated with two different collagen-targeting human basic fibroblast growth factors.
    Zhao W; Chen B; Li X; Lin H; Sun W; Zhao Y; Wang B; Zhao Y; Han Q; Dai J
    J Biomed Mater Res A; 2007 Sep; 82(3):630-6. PubMed ID: 17315233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The collagen-binding leech products rLAPP and calin prevent both von Willebrand factor and alpha2beta1(GPIa/IIa)-I-domain binding to collagen in a different manner.
    Depraetere H; Kerekes A; Deckmyn H
    Thromb Haemost; 1999 Sep; 82(3):1160-3. PubMed ID: 10494781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Collagen-binding mode of vWF-A3 domain determined by a transferred cross-saturation experiment.
    Nishida N; Sumikawa H; Sakakura M; Shimba N; Takahashi H; Terasawa H; Suzuki E; Shimada I
    Nat Struct Biol; 2003 Jan; 10(1):53-8. PubMed ID: 12447349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Expression of von willebrand factor-A3 domain in E coli and its biological function].
    Zhu HP; Wang YC; Ji SD; Bai X; Jiang M; Ruan CG
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2004 Apr; 12(2):199-203. PubMed ID: 15157333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Laboratory diagnosis and molecular basis of mild von Willebrand disease type 1.
    Michiels JJ; Berneman Z; Gadisseur A; van der Planken M; Schroyens W; van Vliet HH
    Acta Haematol; 2009; 121(2-3):85-97. PubMed ID: 19506353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Laboratory diagnosis and molecular classification of von Willebrand disease.
    Gadisseur A; Hermans C; Berneman Z; Schroyens W; Deckmyn H; Michiels JJ
    Acta Haematol; 2009; 121(2-3):71-84. PubMed ID: 19506352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a novel 14-3-3zeta binding site within the cytoplasmic domain of platelet glycoprotein Ibalpha that plays a key role in regulating the von Willebrand factor binding function of glycoprotein Ib-IX.
    Yuan Y; Zhang W; Yan R; Liao Y; Zhao L; Ruan C; Du X; Dai K
    Circ Res; 2009 Dec; 105(12):1177-85. PubMed ID: 19875727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recessive von Willebrand disease type 2 Normandy: variable expression of mild hemophilia and VWD type 1.
    Michiels JJ; Gadisseur A; Vangenegten I; Schroyens W; Berneman Z
    Acta Haematol; 2009; 121(2-3):119-27. PubMed ID: 19506358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression in Escherichia coli of a recombinant fragment (Ile 914-Leu 1364) of human von Willebrand factor containing a collagen binding domain.
    Jorieux S; Piétu G; Gaucher C; Mischler F; Meulien P; Meyer D; Mazurier C
    Blood Coagul Fibrinolysis; 1990 Oct; 1(4-5):375-84. PubMed ID: 2133214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of a fusion protein containing human epidermal growth factor and the collagen-binding domain of Vibrio mimicus metalloprotease.
    Kim DG; Min MK; Ahn SC; Kim JK; Kong IS
    Biotechnol Lett; 2009 Feb; 31(2):259-64. PubMed ID: 18931974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autosomal dominant von Willebrand disease type 2M.
    Hermans C; Batlle J
    Acta Haematol; 2009; 121(2-3):139-44. PubMed ID: 19506360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factor VIII-von Willebrand factor binding defects in autosomal recessive von Willebrand disease type Normandy and in mild hemophilia A. New insights into factor VIII-von Willebrand factor interactions.
    Jacquemin M
    Acta Haematol; 2009; 121(2-3):102-5. PubMed ID: 19506355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.